News
FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback